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LIFETIME EFFECTS OF RESPIRATORY AND LIVER DISEASE ON CATTLE
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Department of Veterinary Science
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Significance of Respiratory and Gastrointestinal Disease
In cattle, the respiratory and gastrointestinal tracts are the main systems affected with
disease.  Bovine respiratory disease (BRD) contributes the majority of illness and death loss in
the feedlot segment.  Historically, 15-45% of feedlot cattle have been affected with BRD, with
1-5% of total cattle placed dying of BRD (Kelly 1986).  Respiratory disease, alone, accounts for
44.1% of deaths in beef feedlot cattle (Vogel 1994).  Apart from death loss, the Texas Ranch to
Rail Program has suggested that clinical disease (most of which is BRD), even if treated
successfully, results in treatment cost ($37.90/affected), decreased average daily gain (0.21 lb/d,
for a 7.2 % decrease), decreased feed efficiency, and a decrease in quality grade (27% fewer
choice).  Together, these contribute an economic loss of approximately $88.00/ affected animal
(Anonymous 1994). 
Not restricted to the feedlot, respiratory disease accounts for 16% of the known causes of
death in nursing calves, second in importance only to weather, and apparently increased from
estimates made 5 years earlier (USDA/APHIS/VS 1994, 1997).  Though the incidence of
respiratory disease in unweaned calves is generally thought to be low, (1-2%), individual herds
can have up to 65% of calves affected prior to weaning (Muggli-Cockett 1992).  Unweaned
calves affected with respiratory disease have a 36.3 lb reduction in weaning weight (Wittum
1994).  This reduction, coupled with treatment cost, is the main economic loss from BRD in the
cow-calf segment. 
Disease of the gastrointestinal tract is the second most common cause of death in the
feedlot (Vogel 1994). Acidosis is a common condition in feedlot cattle, and liver abscesses are a
possible sequella.  Slaughter surveys indicate that about 12% of beef cattle livers are condemned
due to liver abscesses (Smith 1998).
Recently completed work indicates that productive losses associated with BRD are
greater than previously thought.  Liver abscesses continue to be a significant problem.  With the
beef industry desiring to maximize productive potential, minimize inputs, and potentially limit
the use of antimicrobials, an understanding of the biology of disease is necessary to better
control these problems.  Understanding of the disease process, particularly respiratory disease,
implicates events in early life as risk factors for subsequent illness.
Subclinical Bovine Respiratory Disease
BRD has been regarded as a visually obvious, clinical disease with signs including
depression, lack of abdominal fill, altered breathing pattern, fever, coughing, and nasal
discharge.  It has generally been assumed that cattle identified with clinical BRD represent the
total BRD loss.  However, recent work has indicated that respiratory disease does not always
present as a clinical condition, and can occur as a subclinical disease.  Subclinical BRD presents
with no obvious physical signs of respiratory disease, yet the lung is affected with inflammation
indicative of pneumonia.
Studies examining slaughter cattle indicate that lung lesions, indicative of prior
respiratory disease, are common.  Many cattle with lung lesions have no history of prior
respiratory disease, and these cattle have assumedly undergone subclinical bovine respiratory
disease.  A series of investigations using a standardized lung examination system has been
completed (Bryant 1996).  Lungs of 1,326 slaughtered cattle from 4 feedlots were examined. 
Lung lesion prevalence, recorded in commercial slaughter plants, varied from 33.6% - 76.5%,
depending on feedlot and pen within feedlot.  Lung lesions suggestive of previous BRD were
associated with decreased average daily gain (ADG) of between 0.07-0.14 lb/day (Bryant 1997). 
Another study, using more intensive lung examination, recorded a lung lesion prevalence
of 72% (Wittum 1996).  Clinical BRD occurred in 29% of these calves in the feedlot, and in an
additional 8% from birth to weaning.  Though calves with clinical BRD were more likely to have
lung lesions at slaughter, 68% of calves never observed with clinical BRD had lung lesions. 
Lung lesions were associated with a 0.167 lb/day reduction in ADG, while clinical BRD did not
effect ADG.  Clearly, clinical BRD represents only a portion of respiratory disease, and
subclinical BRD may be a common, costly condition associated with feedlot performance.  In
addition to performance, marbling or muscle tenderness may be negatively impacted by lung
lesions (Gardner 1998, Whitley 1999).
The "cause" of subclinical BRD is, at present, not known.  It is not known when, in the life of the
calf, lung lesions form.  It is likely that the risk factors for subclinical BRD are similar to those
for clinical BRD, but this is unproven.  The lung lesions typical of inhalation pneumonia are the
only lesion type associated with decreased ADG (Bryant 1997, Gardner 1998).  Inhalation
pneumonia is a well-recognized form of clinical BRD, suggesting that subclinical BRD is a
different manifestation of the clinical BRD disease process.  
Prevention of BRD
Risk factors associated with clinical BRD include many bacterial and viral agents (Dyer
1981).  These agents are all very common in the cattle population, and many are natural
residents of the upper respiratory tract of cattle.  It is generally regarded that clinical BRD is the
result of a breakdown of natural defense systems that allow these agents to establish in the lower
respiratory system (Dyer 1982).
It appears that risk factors for clinical BRD are at work very early in life. Calves that do
not ingest adequate colostrum shortly after birth have a 3.2 fold increased risk of disease from
birth to weaning, a 3.1 fold increased risk of clinical respiratory disease in the feedlot, and a
0.088 lb decrease in feedlot ADG (Wittum 1995).  Other diseases, such as calf diarrhea, lead to
increased risk of pneumonia prior to weaning, as well as decreased growth rates (Ganaba 1995). 
Weather stress may decrease calf resistance to disease, and cow nutrition plays a yet poorly
defined role in disease resistance (Corah 1993, Odde 1988).  During the grazing season, trace
mineral nutrition on pasture may be important in preventing post-weaning BRD, and
preconditioning/preweaning vaccination can help increase calf resistance to disease (Larson
1995).  It has been suggested that a complete preconditioning program may decrease clinical
feedlot respiratory disease 23%, and feedlot death by 40% (Cole 1985).  Auction market owners
and cattle buyers prefer calves with a history of vaccination administration, and these calves 
appear to receive modest premiums (Henderson 1995, King 1997).  Calf sex, age distribution of
the cow herd, year, and breed of dam may influence BRD in the postweaning period (Muggli-
Cockett 1992).
Events occurring near or at weaning and transport play important roles in BRD. 
Weather, dust level, commingled sourcing, nutrition, processing, strategic medication, and
transportation factors influence subsequent feedlot disease (MacVean 1986, Martin 1982,
Wilson 1985, Cole 1985, Ribble 1994, Young 1995, Schumann 1991, Harland 1991).
Seemingly, clinical and subclinical BRD are caused by numerous risk factors that act in
an additive manner.  Some of these, like herd demographics, may be determined before birth,
others, like colostral acquisition, are determined shortly after birth, while still others are
determined at later times on the ranch of origin or at the feedlot.  The relative contribution of
each factor to lifetime performance is unknown.  There is need to attempt to prioritize these risk
factors, looking at lifetime calf performance as the outcome of interest.
Liver Abscesses
Liver abscesses are the result of transfer of bacteria, mainly Fusobacterium necrophorum
(previously called Sphaerophorus necrophorus) to the liver from the rumen (Jensen 1954).  This
transfer occurs when normal rumen defenses are impaired, usually when the internal lining
(mucosa) of the rumen is damaged.  When mucosal damage occurs, often secondary to rumen
acidosis, bacteria can enter the bloodstream and go to the liver.  Fusobacterium necrophorum
has some unique characteristics that enable it to evade normal liver defenses and establish an
infection focus (Nagaraja 1996).  The bacteria stimulate an inflammatory reaction of neutrophils,
and the end result is a liver abscess.  Liver abscesses may resolve with time and disappear,
leaving only a scar.  However, large abscesses or persistent insults are likely to remain present
for some time.
Liver abscesses can be observed in slaughtered cattle.  The prevalence varies by feedlot
and even by pen within feedlot, but about 12% of beef cattle slaughtered have severe liver
abscesses.  Livers affected with severe abscesses are condemned for human consumption.  This
loss amounts to about 11 lbs, and constitutes an economic loss of $5-6 per affected carcass
(Smith 1998).
Research has indicated that cattle affected with severe liver abscesses have decreased
slaughter weight, decreased carcass weight, decreased fat thickness, and decreased dressing
percentage (Brink 1990, Montgomery 1985).  On a carcass basis, they have decreased dry matter
intakes and lower feed efficiency (Brink 1990).  There has been no published work that indicates
quality grade is adversely affected by liver abscesses, though some studies have suggested this
possibility (Montgomery 1985).
Liver abscesses are mainly associated with grain feeding, probably because grain feeding
results in large increases in rumen Fusobacterium necrophorum populations (Tan 1994). 
Animals affected with liver abscesses exhibit no direct clinical signs of illness.  Liver abscess
control has traditionally relied on in-feed antimicrobials.  The 1999 feed additive compendium
lists 5 feed additives labeled for liver abscess control.  Tylosin (Tylan®) at 60-90 mg/head/day
has been popular, and reduces liver abscesses by 73% (Vogel 1994).  Feed additive
antimicrobials appear to work by simply decreasing rumen Fusobacterium necrophorum
populations, thereby decreasing exposure to high bacterial levels (Nagaraja 1999).  There has
been recent concern about antibiotic use that has prompted the European Union to ban most feed
additives, including tylosin.  It is unknown whether this ban will be permanent in the EU, or
whether some form of restricted use of feed additives may appear in the US.  There is little
scientific evidence to suggest that Fusobacterium necrophorum has acquired resistance to the
common feed additive antibiotics (Lechtenberg 1998).  However, this does not eliminate the risk
of selecting for antibiotic resistance among other bacteria (Prescott 1993).  Therefore, other
methods of liver abscess control are needed.
Experimental vaccines have been used in attempt to decrease liver abscesses, with some
past success (Garcia 1974).  Recent reports have again indicated that vaccination can decrease
liver abscess prevalence at slaughter (Terhaar 1996).  Currently, a vaccine product is licensed for
liver abscess control in the US.  The product is reported to decrease liver abscesses at slaughter
by 48-61%.  In addition to liver abscess control, effective immunization against Fusobacterium
necrophorum may also provide control for footrot, since footrot is also associated with
Fusobacterium necrophorum infection.
Better control of liver abscesses is needed since they continue to be a prevalent condition
of slaughter cattle and are associated with reduced performance and economic loss.  Control
through reliance on antimicrobials appears to be a politically dangerous position.  Other methods
of control, including immunologic, need to be examined.  Such methods will likely require
cooperation in the cow-calf and stocker sectors for maximum benefit.  
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